Atlas Trials

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Clinical trial NCT03878524 · TERMINATED

Trial details

NCT number
NCT03878524
Sponsor
OHSU Knight Cancer Institute
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAnatomic Stage IV Breast Cancer AJCC v8AnemiaAnn Arbor Stage III Hodgkin LymphomaAnn Arbor Stage III Non-Hodgkin LymphomaAnn Arbor Stage IV Hodgkin LymphomaAnn Arbor Stage IV Non-Hodgkin LymphomaAtypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveCastration-Resistant Prostate CarcinomaChronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveHematopoietic and Lymphoid System Neoplasm
Start date
2020-04-01
Primary completion
2020-12-10
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.